What started as a conversation about a new app, became a story about how new technology from a company called Paragonix has transformed organ transplants.The Latest Tech News, Delivered to Your Inbox ...

THE aroma of melting chocolate regularly fills Rachel Treen’s house leaving her craving a bar of Dairy Milk.  But she’s not an avid baker, no, the 26-year-old lives in Bourneville, ...

Minnesota Vikings Hall of Fame wide receiver Randy Moss and ESPN, his current employer, issued major news one day before ...

Rassameehiran is a specialist in treating patients with conditions that affect the stomach, intestines, liver, and pancreas. She is one of only two gastroenterologists currently practicing on Guam ...

During the conference, Can-Fite's management team will engage in one-on-one meetings with investors and potential partners to discuss the company’s business strategy, recent clinical milestones, and ...

GILL Nibbs was a “vibrant” woman who lived a seemingly perfectly healthy lifestyle.  “She walked everywhere, didn’t smoke or ...

Rare cancers are less known and pose challenges due to limited research and diagnostic difficulties. Environmental factors, ...

The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...

BMI: Heart size can be significantly affected by BMI, with obese people having larger hearts. One study showed that people with obesity (BMI greater than or equal to 30) have larger kidneys, liver, ...

Nivolumab plus ipilimumab (N+I) in patients (pts) with pancreatic cancer (PC) with BRCA1/2 mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study. Overall ...

Impact of neoadjuvant radiation therapy modalities on post-surgical lymphopenia in operable pancreatic cancer. Demographic characteristics of patients classified according to “two-two five-five” ...

The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class of drugs called glucagon-like peptide-1 agonists, or GLP-1.